Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 17:20:2493-2523.
doi: 10.2147/COPD.S510623. eCollection 2025.

A Systematic Literature Review of the Humanistic, Economic, Sociodemographic, and Environmental Burden Associated with Severe COPD

Affiliations

A Systematic Literature Review of the Humanistic, Economic, Sociodemographic, and Environmental Burden Associated with Severe COPD

Ioanna Vlachaki et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Chronic obstructive pulmonary disease (COPD) is a highly prevalent and progressive disease, hence greater understanding of its humanistic, economic, and environmental impact is essential for guiding effective management strategies. A systematic literature review (SLR; 2021-2023), complemented with a targeted literature review (TLR; 2013-2023) identified 2039 publications on the economic and humanistic burden of severe COPD. Additionally, an SLR and complementary TLR to evaluate the impact of environmental and sociodemographic factors on COPD (2013-2023), identified 1018 records. All searches were conducted on November 17, 2023. After applying prespecified selection criteria, 50 studies reporting on the humanistic and economic impact of COPD, and six studies on the environmental and sociodemographic impact, were selected. Severe COPD significantly impairs health-related quality of life, exerting effects on physical and psychological well-being, with a progressive decline as COPD worsens from mild to very severe. Evidence indicates that there is a significant burden of disease due to exacerbations of COPD, with their frequency and severity increasing with disease progression, and an increased mortality risk associated with very severe versus severe COPD. The studies reported a high frequency of healthcare resource utilization, including primary care visits, emergency department visits, and hospitalizations among patients with severe COPD, all of which contribute to a significant economic burden, particularly in patients with advanced disease. Environmental factors demonstrated diverse impacts on outcomes for individuals with severe COPD, varying by type of pollutant, disease severity, and patient characteristics. Studies examining the sociodemographic impact of underserved populations on the burden of severe COPD were not identified. Severe COPD is a multifaceted disease that imposes considerable humanistic and economic impact on both patients and healthcare systems. Further work is needed to understand the impact of environmental and sociodemographic factors on the burden of COPD, with such insights ultimately optimizing patient care.

Keywords: COPD; costs; environmental impact; healthcare resource utilization; quality of life.

PubMed Disclaimer

Conflict of interest statement

Robert A. Wise receives research grant support from AstraZeneca, Chiesi, Sanofi-Regeneron, and Verona; and consulting fees for serving on DSMB or Clinical Endpoint Committees from AstraZeneca, Boehringer Ingelheim, Chiesi, Galderma, Kamada, Pulmonx, and Savara. Jennifer K. Quint has been supported by institutional research grants from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Health Data Research, Insmed, Medical Research Council, NIHR, and Sanofi; and received personal fees for advisory board participation, consultancy or speaking fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, and Sanofi. Ioanna Vlachaki, Alessandra Madoni, Simon Donhauser, and Ulrica Scaffidi Argentina are employees of Chiesi Farmaceutici S.p.A, the funder of this work. Jahangir Nabi Mir is an employee of IQVIA, which received funds from Chiesi Farmaceutici S.p.A for the conduct of this work. The authors report no other conflict of interest to disclose.

Figures

Figure 1
Figure 1
PRISMA flow diagram for humanistic and economic burden (A) and environmental and sociodemographic impact (B).
Figure 2
Figure 2
Continued.
Figure 2
Figure 2
Patient-level direct healthcare costs in Germany (A), Spain (B), and China (C), and COPD-related direct healthcare costs in the US according to FEV1% predicted (D), and GOLD stage (E).

Similar articles

References

    1. World Health Organization. Chronic obstructive pulmonary disease (COPD) factsheet; November 6, 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pul...). Accessed April 28, 2025.
    1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD: 2024 report. 2024. Available from: https://goldcopd.org/2024-gold-report/. Accessed April 28, 2025.
    1. World Health Organization. Smoking is the leading cause of chronic obstructive pulmonary disease. Departmental update. November 15, 2023. Available from: https://www.who.int/news/item/15-11-2023-smoking-is-the-leading-cause-of.... Accessed April 28, 2025.
    1. Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–458. doi: 10.1016/S2213-2600(21)00511-7 - DOI - PMC - PubMed
    1. Boers E, Barrett M, Su JG, et al. Global burden of chronic obstructive pulmonary disease through 2050. JAMA Network Open. 2023;6(12):e2346598. doi: 10.1001/jamanetworkopen.2023.46598 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources